You may already know a lot of the names that are considered leaders of the diabetes technology industry. The likes of Abbott and Dexcom are leaders in the continuous glucose monitor (CGM) space. MiniMed, Insulet and Tandem Diabetes Care are a few of the companies with a significant share in the automated insulin delivery (AID) […]
modularmedical
Modular Medical to initiate first phase of Pivot pump launch in October
Modular Medical (Nasdaq:MODD) announced its plans to initiate the first phase of the launch of its Pivot tubeless insulin patch pump. Pivot, designed to make insulin pump therapy simpler to learn and easier to live with, features a removable, two-part design and a 3 mL reservoir, intuitive interface and flexible, wearable form factor. The system […]
Modular Medical inks IMO Health collab for insulin pump EHR integration
Modular Medical (Nasdaq:MODD) announced that it entered into a new pilot collaboration with IMO Health. IMO Health provides healthcare AI solutions designed to transform healthcare data into trusted clinical context. Through this pilot, San Diego-based Modular Medical aims to develop a deployable terminology-powered phenotypic algorithm designed to identify diabetes patients who may benefit from insulin […]
Modular Medical launches Pivot tubeless insulin patch pump
Modular Medical (Nasdaq:MODD) announced today that it commercially launched its new Pivot tubeless insulin patch pump. The rollout marks the start of real-world patient use of the Pivot pump. It marks San Diego-based Modular Medical’s transition to a commercial-stage medical device company. Modular Medical designed Pivot to make insulin pump therapy simpler to learn and […]
Modular Medical wins FDA clearance for Pivot tubeless insulin patch pump
Modular Medical (Nasdaq:MODD) announced today that it received FDA 510(k) clearance for its next-generation insulin patch pump. Pivot, a tubeless patch pump, consists of two parts, with a 3 mL reservoir and a disposable battery. It features smartphone connectivity for bolus and monitoring, plus electronic accuracy without tubes or constant wear. The pump requires no […]
Modular Medical prices $12M public offering to support insulin pump
Modular Medical (Nasdaq:MODD) announced the pricing of a public offering worth proceeds of approximately $12 million. San Diego-based Modular Medical’s offering includes nearly 68.1 million shares of the company’s common stock and warrants to purchase up to an aggregate of 68.1 million shares. The company priced the offering at $0.1762 per share and accompanying warrant. […]
Modular Medical hits validation milestone, targets commercial launch for insulin patch pump soon
Modular Medical (Nasdaq:MODD) announced that it started the production of validation lots for its Pivot tubeless insulin patch pump. The lots include the next-generation Pivot pump’s disposable cartridge and infusion set. With the milestone, the San Diego-based company said it remains on track for a commercial launch in the first quarter of 2026, subject to […]
The top diabetes tech stories of 2025
As the year comes to a close, it’s time to look back at the numerous innovations across the diabetes technology industry in 2025. Once again, continuous glucose monitors (CGMs) and automated insulin delivery systems took most of the headlines, as the leaders in the space keep building on their platforms while challengers continue to enter […]
Modular Medical prices $4.7M public offering
Modular Medical (Nasdaq:MODD) announced that it priced an underwritten public offering of common stock worth approximately $4.68 million. The San Diego-based insulin pump maker intends to offer nearly 12.2 million shares of common stock and accompanying warrants to purchase nearly 6.1 million shares. Each two-share package is being offered and sold together with one accompanying […]
Modular Medical submits next-gen insulin pump to FDA, expects 2026 launch
Modular Medical (Nasdaq:MODD) announced that it has submitted its next-generation Pivot insulin pump to the FDA for clearance. Modular Medical’s current pump, the MODD1, won FDA clearance nearly a year ago. It has microfluidics technology that allows for the low-cost pumping of insulin. The company announced earlier this year that it began converting its manufacturing line to […]
